OLIG1 as a Prognostic Factor in Lung Cancer
Author Information
Author(s): Brena Romulo M, Morrison Carl, Liyanarachchi Sandya, Jarjoura David, Davuluri Ramana V, Otterson Gregory A, Reisman David, Glaros Selina, Rush Laura J, Plass Christoph
Primary Institution: The Ohio State University
Hypothesis
Can aberrant DNA methylation patterns differentiate between adenocarcinomas and squamous cell carcinomas in lung cancer and correlate with patient survival?
Conclusion
OLIG1 protein expression significantly correlates with overall survival in non-small cell lung cancer patients, suggesting it could be a useful prognostic factor.
Supporting Evidence
- OLIG1 protein expression was found to correlate with survival in NSCLC patients.
- Patients with low OLIG1 expression had a higher risk of mortality.
- Multivariate analyses confirmed the significance of OLIG1 as a prognostic factor.
Takeaway
This study found that a protein called OLIG1 can help doctors predict how well lung cancer patients will do, which could help in deciding their treatment.
Methodology
The study used restriction landmark genomic scanning on 40 patient samples to identify DNA methylation patterns and correlated OLIG1 protein expression with survival outcomes.
Limitations
The study's findings need to be validated in a clinical setting to confirm the utility of OLIG1 as a prognostic marker.
Participant Demographics
Patients with non-small cell lung cancer, including both adenocarcinomas and squamous cell carcinomas.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI 0.77–0.91
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website